TSHA icon

Taysha Gene Therapies

108 hedge funds and large institutions have $402M invested in Taysha Gene Therapies in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 28 increasing their positions, 27 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
+22
Holders Change %
+25.58%
% of All Funds
1.57%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
36
Increased
28
Reduced
27
Closed
14
Calls
$453K
Puts
$462K
Net Calls
-$9K
Net Calls Change
-$207K
Name Holding Trade Value Shares
Change
Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$57.7M -$6.68M -2,328,407 -10%
ACA
2
Avoro Capital Advisors
New York
$53.5M +$41M +14,294,445 +328%
RI
3
RTW Investments
New York
$53.4M +$4.88M +1,700,000 +10%
RCM
4
RA Capital Management
Massachusetts
$31.2M -$21.8M -7,600,000 -41%
VA
5
VR Adviser
New York
$25.8M -$4.05M -1,412,872 -14%
Vanguard Group
6
Vanguard Group
Pennsylvania
$17M -$798K -278,153 -4%
Morgan Stanley
7
Morgan Stanley
New York
$14.8M +$13.6M +4,735,814 +1,094%
BBA
8
Baker Bros. Advisors
New York
$11.5M
TCM
9
Tybourne Capital Management
Hong Kong
$10.6M
AG
10
Artal Group
Luxembourg
$10.6M +$70.2K +24,444 +0.7%
ACP
11
Acuta Capital Partners
California
$9.57M -$735K -256,000 -7%
Millennium Management
12
Millennium Management
New York
$9M -$704K -245,215 -7%
OCA
13
Octagon Capital Advisors
New York
$8.7M +$8.7M +3,030,000 New
BlackRock
14
BlackRock
New York
$7.45M -$293K -101,935 -4%
PCH
15
Polar Capital Holdings
United Kingdom
$7.23M
EP
16
Eversept Partners
New York
$6.67M -$4.18M -1,455,123 -38%
EAM
17
Eagle Asset Management
Florida
$5.08M +$5.08M +1,789,394 New
CAC
18
Cowen and Company
New York
$4.45M +$4.45M +1,550,000 New
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$3.76M -$340K -118,519 -8%
Point72 Asset Management
20
Point72 Asset Management
Connecticut
$3.19M -$4.52M -1,574,768 -59%
T. Rowe Price Associates
21
T. Rowe Price Associates
Maryland
$3.16M -$367K -128,004 -10%
SC
22
Stempoint Capital
New York
$3.12M +$3.12M +1,087,785 New
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$3.08M +$2.74M +953,549 +805%
Goldman Sachs
24
Goldman Sachs
New York
$3.04M +$2.8M +975,488 +1,169%
Marshall Wace
25
Marshall Wace
United Kingdom
$2.96M +$2.96M +1,030,657 New